Insulet
Trade Insulet 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PODD
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.
PODD Key Statistics
Stock Snapshot
As of today, Insulet(PODD) shares are valued at $162.00. The company's market cap stands at 11.06B, with a P/E ratio of 35.26.
During the trading session on 2026-06-10, Insulet(PODD) shares reached a daily high of $162.00 and a low of $149.17. At a current price of $162.00, the stock is +8.6% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 1.82M, compared to an average daily volume of 1.79M.
Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $140.63.
Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $140.63.
PODD News
...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably...
Insulet (PODD) announced new clinical results highlighting the “next breakthroughs” in tubeless Automated Insulin Delivery, AID, systems. The data and growing b...
Analyst ratings
89%
of 27 ratingsMore PODD News
Insulet (PODD) just released new clinical data on its future Omnipod 6 and fully closed loop systems, showing improved glucose control across type 1 and type 2...
The FDA is aware that Insulet (PODD) has issued a letter to affected customers recommending certain Omnipod Pods be removed from where they are used or sold, th...
Key Points DexCom is a leading innovator in the continuous glucose monitoring market with a global footprint across 52 countries. Insulet dominates the tubele...
Insulet (PODD) announced its planned activities during the American Diabetes Association, ADA, 86th Scientific Sessions, taking place June 5 – 8, 2026 in New Or...
Insulet (PODD) Corporation announced the U.S. rollout of new algorithm enhancements for the Omnipod 5 Automated Insulin Delivery, AID, System. The updates follo...
In late May 2026, Insulet announced a voluntary medical device correction covering about 7 million Omnipod Pods after detecting a manufacturing defect that can...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.